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ABSTRACT
The DNA-dependent protein kinase (DNA-PK) and
Poly(ADP-ribose) polymerase-1 (PARP1) are critical
enzymes that reduce genomic damage caused by
DNA lesions. They are both activated by DNA
strand breaks generated by physiological and envir-
onmental factors, and they have been shown to
interact. Here, we report in vivo evidence that
DNA-PK and PARP1 are equally necessary for
rapid repair. We purified a DNA-PK/PARP1
complex loaded on DNA and performed electron
microscopy and single particle analysis on its tetra-
meric and dimer-of-tetramers forms. By comparison
with the DNA-PK holoenzyme and fitting crystal-
lographic structures, we see that the PARP1
density is in close contact with the Ku subunit.
Crucially, PARP1 binding elicits substantial con-
formational changes in the DNA-PK synaptic dimer
assembly. Taken together, our data support a func-
tional, in-pathway role for DNA-PK and PARP1 in
double-strand break (DSB) repair. We also propose
a NHEJ model where protein–protein interactions
alter substantially the architecture of DNA-PK
dimers at DSBs, to trigger subsequent interactions
or enzymatic reactions.
INTRODUCTION
DNA double-strand breaks (DSBs) are the most cytotoxic
form of DNA damage. If unrepaired or incorrectly
repaired, they can lead to apoptosis or genome instability.
Two major DSB repair pathways exist: homologous
recombination (HR) and non-homologous end joining
(NHEJ) (1). In the presence of sister chromatids acting
as templates for repair, DSBs can be repaired by HR.
In NHEJ, the DNA broken ends are resected and/or pro-
cessed and the DNA backbones ligated to restore strand
continuity without the need for a template.
The DNA-dependent protein kinase (DNA-PK)
heterotrimeric enzyme is the early player in mammalian
NHEJ (2). DNA-PK is formed by a DSB recognition
module, called Ku (preassembled as a heterodimer of the
Ku70 and Ku80 proteins) (3) and a large catalytic subunit
(DNA-PKcs,  0.5MDa) (4,5). After recognizing and
binding to a DSB, Ku recruits the catalytic subunit
via the C-terminal domain of the Ku80 subunit.
DNA-PKcs is a serine/threonine kinase belonging to the
phosphatidylinositol-3-OH kinase (PI3K)-related (PIKK)
family. DNA-PK assembles on DNA as a bridging
complex, where two heterotrimers maintain the two
DNA broken ends in close proximity, providing a scaf-
folding platform to recruit further NHEJ enzymes (6).
These factors include Artemis and PNK, which are
required to process the broken ends; X family polymer-
ases, which promote microhomology and cohesion
between the broken ends; DNA ligase IV-XRCC4,
which closes the phospho-diester backbone on both
strands, and the XLF/Cernunnos factor (7). Autophos-
phorylation sites, crucial to NHEJ regulation, have been
identiﬁed in DNA-PKcs at two main clusters, as well as
within its catalytic domain (7). A recent electron micros-
copy study visualized a substantial remodeling of
DNA-PK on autophosphorylation (8).
PARP enzymes use nicotinamide as a substrate to
polymerize ADP-ribose moieties onto target proteins, a
process called poly-ADP-ribosylation (or PARylation)
(9). The best-studied PARP enzyme is PARP1, which
has a key role in DNA repair and in particular single-
strand break repair/base excision repair (10). PARP1
detects and binds single strand DNA breaks and then
poly-ADP-ribosylates itself (auto-PARylation) and other
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and binds to them, both in vivo and in vitro (11). PARP1
is a 113kDa enzyme with three functional domains:
an N-terminal DNA-binding domain, a central
automodiﬁcation domain, and a C-terminal catalytic
domain.
Genetic interaction between DNA-PK and PARP was
initially related to recombinational events (12). The
cross-talk between DNA-PK or its component Ku70:80
and PARP1 within NHEJ and V(D)J recombination has
been described in various independent studies (13–21).
A recent study, focusing on the role of PARP1 in V(D)J
recombination, reports that the immunoprecipitation of
the BRCT domain of PARP1 pulls down Ku70 and the
DNA-PK complex in a DNA-independent manner (22).
This ﬁnding suggests that PARP1 modulates DNA-PK in
gene conversion, and that this is mediated through BRCT
domain-mediated interactions. Alternatively, an import-
ant and DNA-PK-independent role of PARP1 in NHEJ
has recently emerged. PARP1 is proposed to operate
in an alternative NHEJ pathway, which backs up
the classical pathway and is particularly active in
microhomology-facilitated NHEJ (23,24). Recent data
indicate that PARP1 can modulate competition between
HR and NHEJ -PARP inhibition alone causes cell death
in HR-defective, e.g. BRCA1 mutant cells. However it
now appears that co-inactivation of NHEJ (by inactiva-
tion of DNA-PKcs or 53BP1) rescues BRCA1 mutant
cells from PARP inhibitor cytotoxicity (25,26). These
roles of PARP1 are not mutually exclusive, however
they need a much ﬁner characterization to fully under-
stand the interplay of PARP1 and other repair factors.
DNA-PKcs and DNA-PK have been at the centre of
numerous structural studies in the last 15 years. X-ray
crystallography, NMR, electron microscopy (EM) and
SAXS have all contributed to our understanding
of these proteins, either in isolation or in complex
(6,27–37). We were the ﬁrst in visualizing DNA-PK
synaptic dimers by electron microscopy and single
particle analysis (6). Our ﬁndings were later supported
by a SAXS study, where DNA-PK synaptic dimers
loaded on a Y-shaped DNA were shown to arrange in
the same way in solution as in our single particle
analysis (37). DNA-PK dimers loaded on hairpin DNA
produced a different architecture in solution, with
DNA-PKcs heads (and therefore kinase domains) in
close proximity. This shows the plasticity of DNA-PK,
which responds to different macromolecular interactions
with substantial architectural rearrangements. Recently,
we showed how autophosphorylation has a dramatic
structural effect on DNA-PK dimers, causing disassembly
and structural heterogeneity (8).
The structural data available for PARP1 are so far
limited to its isolated domains, probably due to its size
and ﬂexibility. The human PARP1 enzyme is a modular
protein of 113kDa. Three zinc ﬁnger domains, Zn1–Zn3,
are located at its extreme N-terminus. An internal
automodiﬁcation region contains a BRCT domain
involved in mediating protein–protein interactions and
three lysines that are targeted for automodiﬁcation. The
catalytic domain is located at the extreme C-terminus of
the enzyme. The crystal structure of the catalytic domain
(38) led to the development of a major breakthrough in
structure-based drug design: PARP inhibitors are current-
ly in clinical trials for the treatment of breast cancer (39).
A crystal structure has recently been solved for the
Zn3 domain (40). Early DNA binding studies using a
Zn1–Zn2 domain fragment suggested that PARP1 binds
to DNA as a dimer (41), and kinetic analysis of PARP1
activity indicated that PARP1 is a catalytic dimer (42).
However, more recent data suggest that the Zn1–Zn2
fragment recognizes DNA single-strand breaks as a
monomer (43). A direct interaction between Ku and
PARP1 has been described (22), however the stoichiom-
etry of the Ku/PARP1 assembly has not been investigated
to date.
Here, we present in vivo data on the effect of DNA-PK
and PARP1 inhibitors in repair competent cell lines, as
well as in cells deﬁcient in either DNA-PK or PARP1.
Our data highlight that, upon exposure to a clinically
relevant dose of radiation (2Gy) (44), gH2AX foci,
which mark DNA DSBs (45), were formed. We show
lack of additivity of the two inhibitors in DNA-PK proﬁ-
cient V3-YAC cells, and a PARP inhibitor KU-0058684
having no further impact on the repair of DSBs in
DNA-PK deﬁcient V3 cells. The same trends were
observed with PARP1 deﬁcient and proﬁcient cells
treated with a DNA-PK inhibitor or combination of
inhibitors.
Although a DNA-PK/PARP complex has been
described in biochemical studies, no structural data is
currently available for it. To understand the nature of
the DNA-PK/PARP1 interplay, we performed structural
studies of the puriﬁed DNA-PK/PARP1 complex loaded
on DNA, analysed by electron microscopy and single
particle analysis. We identiﬁed and analysed the structure
of DNA-PK/PARP1 heterotetramers and dimers-of-tetra-
mers. A tight interaction surface between the Ku dimer
and PARP1 within these complexes is apparent. Fitting of
the PARP1 catalytic domain into the EM map is consist-
ent with it not being in direct contact with Ku, supporting
the fact that the BRCT domain may be its interactor.
Our ﬁtting also supports a model where one PARP1
subunit is involved in the complex with DNA-PK,
opposite to the homodimerization occurring in free
PARP1. The architecture of DNA-PK/PARP1 dimers is
strikingly different from the DNA-PK assemblies we
analysed in the past (6,8,46) and from those reported in
SAXS studies on Y-shaped DNA (37). In the presence of
PARP1, the catalytic domain of one of the DNA-PKcs
molecules involved in the complex is in direct contact
with the arm domain of its DNA-PKcs counterpart,
supporting the possibility of an autophosphorylation in
trans (47). The DNA-PKcs catalytic domains are not in
the same orientation as in the SAXS analysis of DNA-PK
loaded on hairpin DNA. This would suggest a role for
PARP1 in modulating DNA repair by eliciting a major
architectural rearrangement of the DNA-PK-mediated
synapsis, as well as supporting a high degree of conform-
ational articulation of DNA-PK in response to diverse
stimuli.
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Inhibitors
The DNA-PK inhibitor NU7441 (48) and the PARP1
inhibitor KU-0058684 (49), synthesized by Newcastle
University, UK, and KuDOS Pharmaceuticals
(Cambridge, UK), respectively, were dissolved in 100%
(v/v) dimethyl sulfoxide (DMSO) at stock concentrations
of 2mM and 200mM, respectively, and stored at  20 C.
Drugs were added in 1% (v/v) ﬁnal DMSO concentration,
and control cells were exposed to 1% DMSO. NU7441
(IC50 for DNA-PK inhibition=14nM) was used at
1mM as previously described (50). KU-0058684 (IC50
for PARP1 inhibition=3.2nM) was used at 100nM.
Cell lines and culture
Primary PARP1
+/+ and PARP1
 /  mouse embryonic
ﬁbroblasts (MEFs) were a gift from Professor Gilbert de
Murcia, France (51). Chinese hamster ovary cell lines V3
(mutated in DNA-PKcs) and V3 YAC (V3 transfected
with yeast artiﬁcial chromosome containing human
DNA-PKcs cDNA) were provided by Dr Penny Jeggo,
UK (52). Cell lines were cultured in RPMI 1640+10%
(v/v) fetal calf serum and 1% (v/v) penicillin–
streptomycin. V3 YAC cells were maintained under anti-
biotic selection with 500mg/ml geneticin to ensure YAC
retention. PARP and DNA-PK activities of these cell lines
have been described previously (20,53).
DNA double strand break determination by gH2AX
immunoﬂuorescence
DSBs were detected by gH2AX immunoﬂuorescence
assays utilizing an anti-phospho H2AX antibody as
previously published (anti ser139, clone JBW301,
Upstate, now Millipore Corp., USA) (54). NU7441 and
KU-0058684 were added to cells 1h before 2Gy
X-irradiation (Gulmay D3300 X-Ray System, Gulmay
Medical Ltd., UK) as previously described (50,54).
Image capture was performed as previously described
(54), recording 2 viewﬁelds each containing 20 nuclei.
Mean focus number per nucleus was converted to
foci/pg DNA present to account for different cellular
DNA content (determined by picogreen DNA quantita-
tion assay, Qiagen, UK). DNA repair was calculated as
percent focus loss.
Isolation of the DNA-bound DNA-PKcs/Ku70/Ku80/
PARP1 complexes
The complex containing DNA-PKcs, Ku70, Ku80 and
PARP1 was puriﬁed from HeLa nuclear extract
(CilBiotech, Belgium) with a buffer system based on
20mM HEPES (pH 7.5), 1mM DTT, 0.5mM EDTA,
0.001% b-octylglucoside and 10% glycerol, with NaCl
concentrations ranging from 50 to 1000mM in different
chromatographic steps. After fractionation on heparin
and dsDNA cellulose resins (GE Healthcare, Sweden),
fractions containing DNA-PKcs, Ku70 and Ku80 were
loaded onto a 1ml HiTrapQ column (GE Healthcare,
Sweden) and eluted with a linear NaCl gradient. This
differs from our previous protocol for the puriﬁcation of
DNA-PK heterotrimer (6), since we used a HiTrapQ
column instead of a Resource Q column, therefore obtain-
ing a less stringent fractionation of proteins interacting
with Q resin. Fractions containing all three protein com-
ponents were incubated with -phosphatase for 1h at 4 C.
The sample was incubated for an additional hour at 4 C
with dsDNA iminobiotinylated at the 50-end of the longer
oligo (IBA GmbH, Germany). The sequences of the
oligos (with the linear duplex segments in uppercase) are
shown in Table 1.
The samples were then loaded on a 18–60% glycerol
gradient, with the buffer system 20mM HEPES
(pH 7.5), NaCl 200mM, 1mM DTT, 0.5mM EDTA,
0.001% b-octylglucoside. Further separation was
achieved by using a Beckman SW28 rotor, spinning for
72h at 25000rpm. Fractions were collected from
the bottom and analysed by means of SDS–PAGE on
4–12% Bis-Tris NOVEX gradient gels (Invitrogen, UK).
This analysis highlighted the co-migration of stoichio-
metric quantities of an additional protein with the three
protein components of DNA-PK (Figure 2B). The fourth
protein species was identiﬁed as PARP1 by mass
spectrometry and immunoblotting (data not shown).
Electron microscopy and single-particle analysis of
negatively stained DNA-PKcs/Ku70/Ku80/PARP1
complexes
The DNA-PKcs/Ku70/Ku80/PARP1 sample was applied
to carbon-coated grids, negatively stained with 1% uranyl
acetate and observed in a JEOL 1200EX electron micro-
scope operating at 100kV. Micrographs were recorded at
a calibrated magniﬁcation of 34000  under low-dose
conditions and digitized with a Nikon Coolscan scanner.
A total of 21000 molecular images were extracted with the
Boxer program from the EMAN package, processed and
reﬁned with a combination of EMAN (55), IMAGIC-5
(56) and Spider (57) routines. 3D ﬁtting experiments
were performed using Chimera (58).
RESULTS
DNA-PK and PARP1 lack additivity in DSB repair
We studied the role of PARP1 in the cellular response to
clinically relevant IR doses by measuring DNA DSB
repair in DNA-PK
+/+ (V3-YAC), DNA-PK
 /  (V3),
Table 1. Oligos used to assemble the structured DNA on which the DNA-PK/PARP1 complex is loaded
Oligo A Biotin-50-CGCGCCCAgctttcccagctaATAAACTAAAAACTATTATTATGGCCGCACGCGTCCACCATGGGGTACAACT-30
Oligo B 50-AGTTGTACCCCATGGTGGACGCGTGCGGCCATAATAATAGTTTTTAGTTTATTGGGCGCG-30
Upper case: bases annealing to for dsDNA. Lower case: bases forming a loop.
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+/+ and PARP1
 /  cells. After irradiation of
PARP1 proﬁcient cells, DNA DSBs were rapidly
induced as determined by gH2AX focus formation after
2Gy IR (Figure 1). In repair-competent cell lines and con-
sistent with our previous data with these cells (19) and
independent data (59), DSB resolution followed a
biphasic pattern. There was a rapid resolution of DSBs
during the ﬁrst 2h with 80±24% and 71±10% being
repaired in PARP1
+/+ and V3-YAC cells, respectively.
However, PARP1
 /  MEFs and DNA-PKcs deﬁcient
V3 cells followed a different repair kinetics, with a much
slower rate such that only 27±21% and 25±9%,
respectively, had been repaired.
We have previously shown that the DNA-PK inhibitor,
NU7441, at 1mM radiosensitized V3-YAC cells but not
V3 cells and inhibited DSB repair in SW620 cells (50).
Investigation of the speciﬁcity of the inhibitors for their
target at the DNA repair level revealed that NU7441 in-
hibited repair in the V3-YAC cells (20.6±20.3% repair)
but not V3 cells, such that there was no difference in repair
between V3-YAC+NU7441 and V3 cells (± NU7441) at
2h (Figure 1 A). Similarly, we previously showed that
PARP inhibition radiosensitized PARP
+/+ cells but not
PARP1
 /  cells (53). In the current study, the PARP
inhibitor, KU-0058684, at 100nM, a concentration that
completely inhibited PARP activity in permeabilized
cells (data not shown) retarded repair in the PARP1
+/+
cells but not the PARP1
 /  cells (Figure 1B). We found
that inhibiting PARP in cells lacking DNA-PK, or inhibit-
ing DNA-PK in cells lacking PARP1 had no further
impact on repair (Figure 1C). This ﬁnding, that inhibition
of one enzyme does not further retard repair in a cell line
already lacking the second enzyme, suggests that
DNA-PK and PARP1 may function in the same epistatic
pathway or in a co-operating manner in DSB repair. This
was supported by a non-additive effect of KU-0058684
and NU7441 when utilized in combination in V3 YAC
cells (Figure 1D). Similar effects were observed in
PARP1
+/+ cells (data not shown). Previous research
utilizing PARP inhibitors in DNA-PK-defective V3 cells
has been ambiguous—early research showed V3 cells were
hypersensitive to the PARP inhibitor, 4-amino-1,8-
naphthalimide (60) but these have not been replicated
using the more potent and speciﬁc inhibitor, AG14361
(61), suggesting a compound-speciﬁc rather than
class-effect.
Electron microscopy analysis of the DNA-PK/PARP1
complex reveals additional density compared to the
DNA-PK complex
DNA-PK and PARP1 have been shown to interact
in several studies in the past. We puriﬁed to homogeneity
a human DNA-PKcs/Ku70/Ku80/PARP1 complex
assembled on DNA from non-irradiated HeLa cell
nuclear extracts by batch chromatography, column
chromatography and glycerol gradient centrifugation
(Figure 2A and B). Consistently with earlier independent
data (17), our sample had PARylation and kinase
activities (data not shown).
AB
CD
Figure 1. The effect of DNA-PK and PARP inhibitors on DSB repair. The recovery from IR-induced DSBs in the presence, or absence, of the
DNA-PK inhibitor NU7441 or the PARP1 inhibitor KU-0058684, or both, was measured with g2HAX assays. (A) The effect on NU7441 on
DNA-PK proﬁcient and deﬁcient cells. (B) The effect of KU-0058648 on PARP1 proﬁcient and deﬁcient cells. (C) The effect of NU7441 on PARP1
deﬁcient cells and KU-0058684 on DNA-PK deﬁcient cells. (D) The combinatorial effect of DNA-PK and PARP1 inhibitors on DNA-PK proﬁcient
cells. Cells were exposed to 2Gy ionizing radiation and allowed to recover. Data are the mean ± standard error of three independent experiments
over a 24-h time course.
Nucleic Acids Research,2012, Vol.40, No. 9 4171Figure 2. Puriﬁcation of the DNA-PK/PARP1 complex. (A) Schematics of puriﬁcation protocol. (B) Silver stained SDS–PAGE analysis of the
puriﬁed complex, showing four apparently stoichiometric bands for the DNA-PKcs, PARP1, Ku70 and Ku80 polypeptides. Electron microscopy and
single particle analysis of the DNA-PK/PARP1 complex. (C) Raw micrograph, showing heterogeneity in the sample (monomeric and dimeric
complexes coexist, in analogy with the DNA-PK complex in isolation). White circles: monomers; white squares: dimers. (D and E) Reference-free
class averages of monomeric complex show heterogeneity, since related views can either have or not have a strong density (indicated by the white
arrow in (E). (F) Class averages used in the ﬁnal 3D reconstruction. (G) Reprojections of the 3D model. (H) 3D model calculated by single particle
analysis, accounting for the volume of the sum of DNA-PKcs, Ku heterodimers and PARP1. I. Fourier Shell Correlation plot.
4172 Nucleic Acids Research, 2012,Vol.40, No. 9Electron micrographs of negatively stained DNA-PK/
PARP1 complex showed clear and detailed molecular
images characterized by different apparent sizes
(Figure 2C), consistent with our previous work on
DNA-PK (6). The observation of individual particles
and their classiﬁcation revealed that the sample was het-
erogeneous due to the presence of both monomeric and
dimeric assemblies, similar to those previously observed
by analysis of DNA-PK preparations (6). We performed
an initial reference-free classiﬁcation using the IMAGIC-5
software. The dimeric assemblies were mainly char-
acterized by ‘T-shape’ architecture. Classiﬁcation of a
sub-set of images representing the monomeric assemblies
revealed that some of these had an extra density adjacent
to the region assigned to Ku in our previous analysis
of the DNA-PK complex (6) (Figure 2D and E).
MSA classiﬁcation, performed using the IMAGIC-5
software and based on classiﬁcation using two
eigenimages, was used to separate molecular images
according to their dimensions, so that the original image
dataset was divided in two stacks corresponding to 14049
monomeric and 6099 dimeric complexes (62). The sub-set
of monomeric complexes was further subjected to succes-
sive rounds of alignment and classiﬁcation in order to
improve the resulting image class-averages. Selected
class-averages were used to calculate a starting 3D
volume by common lines using the Euler program in the
IMAGIC-5 package. During the subsequent reﬁnement of
the 3D map a number of class averages were identiﬁed
which lacked the extra density adjacent to Ku and there-
fore correlated more closely with the DNA-PK structure
previously determined (6). The images forming these class
averages were excluded from the data set used for the
ﬁnal reﬁnement by projection matching performed in
IMAGIC-5. The ﬁnal data set was composed of the
2099 particles, which had the best ﬁt for the bigger
complex. The class averages used for the ﬁnal reconstruc-
tion (Figure 2F) are in good agreement with their corres-
ponding reprojections, indicating consistency in the
analysis (Figure 2G). The resolution of the ﬁnal map
(Figure 2H) was estimated as  35A ˚ at 0.5 FSC
(Figure 2I). The method used to determine resolution
involves splitting a data set into two halves and calculating
two independent reconstructions.
The resulting 3D map of the DNA-PK/PARP1 complex
is  230A ˚ long, 160A ˚ wide and 120A ˚ deep. Within the
map, regions can be readily recognized that are highly
compatible with our previous analyses of DNA-PKcs,
DNA-PK and Ku (6,27–29,63) as well as with the crystal-
lographic structures of isolated components of the
complex (35,64) (Figure 3). An extra density compatible
with the size of full-length PARP1 can be visually located
in contact with Ku (Figures 2H and 3). This observation is
consistent with previous data showing genetic interaction
between DNA-PK and PARP1 and the formation of
a Ku/PARP1 complex (12–18), as well as for a physical
role of PARP1 in modulating NHEJ.
We performed docking of known X-ray structures for
DNA-PKcs (3KGV), truncated Ku (1JEY) and PARP1
catalytic domain (2PAW) using UCSF Chimera (58).
To facilitate the manual ﬁtting of crystallographic struc-
tures into portions of the map, we segmented the
DNA-PK/PARP1 3D map in 13 sections using the
Segger routine, and we then hand-grouped the segments
into three regions accounting for DNA-PKcs, the Ku
heterodimer and a density whose size is compatible with
a protein of the molecular weight of one PARP1 molecule.
We ﬁtted the crystallographic structures for DNA-PKcs
and Ku using the Fit-to-Segment command in Chimera
(Figure 3, DNA-PKcs is coloured red, Ku is coloured
green). We then re-segmented the PARP1 density and
tested the Fit-to-segment routine on the 2PAW pdb
entry (chicken PARP1 catalytic domain, 361 residues
out of 1011, 87% identity between the human and
chicken catalytic domains). This ﬁts well in the density
represented with a blue mesh in Figure 3. The density
represented solid and coloured blue is compatible with
the size of the rest of the human PARP1 protein (1014
residues full-length). The density accounting for PARP1
is 110A ˚ long and 86A ˚ wide. The catalytic domain ﬁts in
Figure 3. Docking known X-ray structures into the DNA-PK/PARP1 density map. We used the UCSF Chimera software (58) to dock known
structures for human DNA-PKcs (red), truncated human Ku heterodimer (green) and chicken PARP1 catalytic subunit (2PAW, blue) into the
DNA-PK/PARP1 3D map.
Nucleic Acids Research,2012, Vol.40, No. 9 4173the region of PARP1, which is not in direct contact with
Ku. This is consistent with the biochemical observation
that the pull-down of Ku is mediated by the PARP1
BRCT domain (22), since the BRCT domain is located
N-terminally to the catalytic site, with the latter being at
the C-terminus of the enzyme.
As a control experiment, we also aligned the monomeric
particles to our cryo-EM reconstruction of DNA-PKcs
(29). We then classiﬁed them using a local MSA mask
centered on the PARP1 density. The particles belonging
to classes, which contained the density, were extracted to
one subset. The particles belonging to classes, which
did not contain the density, were extracted to a second
subset. Particles belonging to classes representing top
views, which are very similar for both complexes, were
combined to both sub-data sets. We then processed
these two subsets (DNA-PK/PARP=5163 particles;
DNA-PK=4903 particles) separately, using the cryoEM
reconstruction for DNA-PKcs as a starting model
and an Eman-based projection matching reﬁnement. As
illustrated in Supplementary Figure S1, these reconstruc-
tions are in agreement with the overall features of the two
complexes. In particular, the additional density for the
PARP1-containing complex is shown in Supplementary
Figure S1B, and the comparison between this DNA-PK/
PARP1 reconstruction and the more detailed one
obtained with a more stringent choice of particles is
shown in Supplementary Figure S1C.
Synaptic DNA-PK/PARP1 dimers show orientation
changes compared to DNA-PK dimers
A total of 3125 dimeric appearances of the DNA-PK/
PARP1 complex were manually extracted to a sub-data
set. They were then analysed in 2D by alignment and clas-
siﬁcation, revealing a ‘T-shaped’ architecture. Each
DNA-PK/PARP1 assembly within class averages of this
dimer-of-heterotetramers retains the general features of
the smaller DNA-PK/PARP1 particles, with a clear
added density attached to the Ku end of the DNA-PK
complex. Importantly, in contrast to DNA-PK dimers
loaded on Y-shaped DNA (Figure 4A) and similarly to
DNA-PK dimers loaded on hairpin DNA, one
DNA-PKcs head domain is located in close contact with
the DNA-PKcs arm domain within the DNA-PKcs
opposite (Figure 4B). The orientation of the two halves
of the complex is however different from the one
of DNA-PK dimers on hairpin DNA (Figure 4C). This
orientation is compatible with the ability to auto-
phosphorylate in trans (47), since the two main
DNA-PKcs autophosphorylation clusters have been
mapped in the HEAT repeats region, forming the arm
and palm domain of DNA-PKcs (64). The dimers-of-
tetramers were analysed as a single stack of particles,
which all seemed to contain the PARP1 density, since all
the class averages calculated present a strong signal at
the same position of the PARP1 density in the tetramer
(white arrowhead in Figure 4B, while the black arrowhead
points to the DNA-PKcs head domain).
DISCUSSION
The interplay between the PARP1 and DNA-PK enzymes
seems to be quite intricate. On one hand, an interaction
between the two enzymes has been reported by several
studies (12–22). On the other hand, other work implies
that they have separate roles within the NHEJ DNA
repair pathway (23,24). However, it may well be that
different roles for PARP1 and DNA-PK coexist in
NHEJ, since these molecules respond to a number of
macromolecular interactions and post-translational
modiﬁcations (36,65), which can seriously affect their
conformation and functional properties.
Here, we describe in vivo data suggesting that DNA-PK
and PARP1 lack additivity in DSB repair. We puriﬁed
a DNA-PK/PARP1 complex, which was tested for both
kinase and PARP activities. This complex is organized in
both ‘monomer-of-heterotetramers’ and ‘dimer-of-
heterotetramers’ assemblies. In both cases, tight direct
interactions of PARP1 with the Ku DNA recognition
module are apparent. This is consistent with independent
biochemical characterizations of a PARP1-Ku interaction,
and with the observation that Ku is needed for
PARP activation by 50-overhang DNA DSBs (19). By
analogy with the DNA-PK heterotrimer and dimer-of-
heterotrimers (6), these complexes do not form in the
absence of DNA. This supports a mechanism of
Figure 4. The dynamic nature of DNA-PKcs in the formation of
dimers, as assessed by electron microscopy and single particle
analysis. (A) DNA-PK dimers on Y-shaped DNA, with head
domains facing opposite. (B) DNA-PK/PARP1 dimers on Y-shaped
DNA, with head domains in close contact. (C) Schematics of the
relative arrangement of DNA-PK head domains in DNA-PK dimers
and DNA-PK/PARP1 dimers, both loaded on Y-shaped DNA.
DNA-PKcs is coloured yellow, apart from the head domain, which is
coloured red. Ku is represented as a blue ring and PARP1 as a green
oval.
4174 Nucleic Acids Research, 2012,Vol.40, No. 9assembly of the complex on its substrate, in the same way
as a number of chromatin remodeling factors. Opposite
to the architecture of PARP1 in isolation, our 3D ﬁtting
experiments show that PARP1 interacts with DNA-PK
in a monomeric form, with the catalytic domain distal
to Ku. In fact, the density for the extra protein is really
well deﬁned, accounting for the volume of only one
PARP1 molecule (not smaller or bigger lumps) with
no blurring which might suggest ﬂexibility in the PARP1
region.
Importantly to our understanding of the functional
mechanisms of this complex, and in contrast to our
previous analysis of DNA-PK dimers-of-trimers loaded
on Y-shaped DNA (6), the DNA-PKcs heads are close
in space, suggesting that in this complex autophos-
phorylation may take place in trans, as reported in
earlier biochemical studies (47). Our study does not
however answer the question of how DNA assembles in
this complex. This might be addressed by future cryo-EM
or small angle neutron scattering studies. This orientation
of the DNA-PK/PARP1 dimer-of-tetramers has some
analogies with the conformation of DNA-PK dimers
loaded on hairpin DNA recently analysed by SAXS
(37), since DNA-PKcs head domains are close in space.
However, the overall architecture of the dimer-of-
heterotetramers is different, as it is arranged in
‘T-shaped’ assemblies. This observation is crucial
towards understanding the function of DNA-PK, since
it shows that this dynamic enzyme can adopt substantially
different conformations not only upon recognition of dif-
ferent DNA structures (37) or upon autophosphorylation
(8), but also upon interaction with other DNA repair
factors. This further structural snapshot within the
DNA-PK interacting network emphasizes the need to
characterize the structures of the full range of DNA-PK
assemblies such as the DNA-PK/XRCC4/LigaseIV
complex in order to fully understand the role of a
pivotal enzyme in the DNA damage response.
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